Synthesis of pyridazino[3,4-b][1,5]benzodiazepin-5-ones and their biological evaluation as non-nucleoside HIV reverse transcriptase inhibitors

被引：16
|
作者：
Heinisch, G
Huber, E
Matuszczak, B
Maurer, A
Prillinger, U
机构：
[1] Inst. of Pharmaceutical Chemistry, University of Innsbruck, Innrain 52a
来源：
ARCHIV DER PHARMAZIE | 1997年 / 330卷 / 1-2期
关键词：
HIV-1 reverse transcriptase inhibition; pyridazino[3,4-b][1,5]benzodiazepin-5-ones; non-nucleoside reverse transcriptase inhibitors;
D O I：
10.1002/ardp.19973300108
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Starting from 3,6-dichloro-N-(2-chIoro-5-nitrophenyl)-pyridazine-4-carboxamide (7) a series of 6,11-dialkylated pyridazino-[3,4-b][1,5]benzodiazepin-5-ones with a 3-chloro-8-nitro, 8-amino, 8-acetylamino, or 8-chloro substitution pattern was prepared via N-alkyl-3-alkylamino-6-chloro-N-(2-chloro-5-nitrophenyl)-pyridazine-4-carboxamides. The new compounds were screened as non-nucleoside reverse transcriptase inhibitors. The influence of the substitution pattern in compounds 10-13 on inhibitory potency is discussed.
引用
收藏
页码：29 / 34
页数：6
相关论文
共 50 条
  • [41] Novel Thiazolidin-4-ones as Potential Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
    Petrou, Anthi
    Eleftheriou, Phaedra
    Geronikaki, Athina
    Akrivou, Melpomeni G.
    Vizirianakis, Ioannis
    MOLECULES, 2019, 24 (21):
  • [42] Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
    Qin, Hua
    Liu, Chang
    Guo, Ying
    Wang, Ruiping
    Zhang, Jianfang
    Ma, Liying
    Zhang, Zhili
    Wang, Xiaowei
    Cui, Yuxin
    Liu, Junyi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (09) : 3231 - 3237
  • [43] Efforts toward chiral non-nucleoside reverse transcriptase inhibitors (NNRTIs): Asymmetric synthesis and biological evaluation
    Han, Xin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [44] Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio) pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
    Wang, Yue-Ping
    Chen, Fen-Er
    De Clercq, Erik
    Balzarini, Jan
    Pannecouque, Christophe
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) : 3887 - 3894
  • [45] Mass Spectrometric Characterization of HIV-1 Reverse Transcriptase Interactions with Non-nucleoside Reverse Transcriptase Inhibitors
    Thammaporn, Ratsupa
    Ishii, Kentaro
    Yagi-Utsumi, Maho
    Uchiyama, Susumu
    Hannongbua, Supa
    Kato, Koichi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (03) : 450 - 454
  • [46] Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or α-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
    Ji, Lei
    Chen, Fen-Er
    De Clercq, Erik
    Balzarini, Jan
    Pannecouque, Christophe
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (08) : 1778 - 1786
  • [47] Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties
    Sriram, D
    Bal, TR
    Yogeeswari, P
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (22) : 5865 - 5873
  • [48] Synthesis and biological evaluation of new conformationally restricted S-DABO hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Wu, Hai-Qiu
    Pannecouque, Christophe
    Yan, Zi-Hong
    Chen, Wen-Xue
    He, Qiu-Qiu
    Chen, Fen-Er
    Balzarini, Jan
    Daelemans, Dirk
    De Clercq, Erik
    MEDCHEMCOMM, 2014, 5 (04) : 468 - 473
  • [49] Synthesis of β-fluorophenethyl halopyridyl thiourea compounds as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Venkatachalam, TK
    Uckun, FM
    SYNTHETIC COMMUNICATIONS, 2004, 34 (13) : 2463 - 2472
  • [50] Synthesis and biological activity of new 6-benzylisocytosine derivatives: non-nucleoside HIV-1 reverse transcriptase inhibitors
    V. T. Valuev-Elliston
    A. V. Ivanov
    B. S. Orlinson
    E. N. Gerasimov
    L. L. Brunilina
    S. N. Kochetkov
    I. A. Novakov
    M. B. Navrotskii
    Pharmaceutical Chemistry Journal, 2012, 46 : 397 - 401
12345